A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breastcancer|Estrogen Receptor Positive Breast Cancer|Estrogen Receptor Negative Neoplasm|Progesterone Receptor Positive Tumor|Progesterone Receptor Negative Neoplasm|Androgen Receptor Gene Overexpression
Interventions: DRUG: DHEA
Sponsor: Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori